Ophthalmology

Challenges in targeting the eye with cell therapy 2:12
Challenges in targeting the eye with cell therapy
Marie Csete • 20 Oct 2021
Future developments in advanced therapies for the eye 1:49
Future developments in advanced therapies for the eye
Marie Csete • 20 Oct 2021
LUMEVOQ gene therapy for LHON 2:40
LUMEVOQ gene therapy for LHON
Magali Taiel • 6 Oct 2021
Challenges in translating iPSC-based AMD therapies to the clinic 2:08
Challenges in translating iPSC-based AMD therapies to the clinic
Masayo Takahashi • 26 May 2021
Manufacturing advanced therapies for AMD 3:10
Manufacturing advanced therapies for AMD
Jane Lebkowski • 8 Apr 2021
hESC-derived RPE for dry AMD 3:21
hESC-derived RPE for dry AMD
Jane Lebkowski • 8 Apr 2021
Horizon scanning of cell therapy: the eye and beyond 2:44
Horizon scanning of cell therapy: the eye and beyond
Jane Lebkowski • 8 Apr 2021
CTNS-RD-04: HSC gene therapy for cystinosis 7:49
CTNS-RD-04: HSC gene therapy for cystinosis
Stephanie Cherqui • 17 May 2021
iPSC-derived RPE for macular degeneration 3:32
iPSC-derived RPE for macular degeneration
Masayo Takahashi • 26 May 2021
Targeting the eye with cell therapy 2:17
Targeting the eye with cell therapy
Jane Lebkowski • 8 Apr 2021
Looking ahead to the Cell & Gene Meeting on the Mediterranean 2021 1:47
Looking ahead to the Cell & Gene Meeting on the Mediterranean 2021
Mike Lehmicke • 17 Mar 2021
LUMEVOQ: gene therapy for Leber hereditary optic neuropathy 2:07
LUMEVOQ: gene therapy for Leber hereditary optic neuropathy
Magali Taiel • 1 Sep 2020
Main areas of progress in stem cell therapies 2:09
Main areas of progress in stem cell therapies
Marc Peschanski • 31 May 2020
The content of VJRegenMed is intended for healthcare professionals